Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. Event details are collected in one workspace.
INTS
$3.44
+7.17%
INTS
· Intensity Therapeutics, Inc.
$3.44
+0.23 (+7.17%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the cash and cash equivalents as of June 30, 2026, the Company's ability to continue its operations thereafter is dependent on obtaining additional capital, which is not within the Company's control. As a result, the Company believes there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$12.41M
Shares
3.26M
Volume · Oct 2
15.44K
Avg daily vol (3M)
28.05K
All webcasts
Annual General Meeting · 2026-12-31
Intensity Therapeutics, Inc. (INTS) December 2026 Annual General Meeting
Research coverage
0 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.